Breaking News
Get 45% Off 0
🤯 +96%, +62%, +40%: These AI-picked stocks are soaring!
See the list

Editor's Picks Analysis & Opinion

Contribute
Geoff Considine, Ph.D
AbbVie Selloff Is A Buying Opportunity By Geoff Considine, Ph.D - Sep 13, 2021

AbbVie (NYSE:ABBV) has recently suffered a sell-off, triggered by the Aug. 31 FDA announcement that the packaging of Rinvoq, its prescription drug for rheumatoid arthritis, will require a warning...

Continue with Apple
Continue with Google
or
Sign up with Email